Arthrex is renowned for its high-quality products, support and reliability since 1981. The company currently employs experts in research, development, and marketing around the globe, all of whom work in accordance with the company’s guiding principle “Helping Surgeons Treat Their Patients Better”.
Arthrex is one of the world’s leading companies in the field of biotechnology and millions of Arthrex ACP double syringes have been used by physicians all over the world since 2007.
The versatility of Arthrex ACP double syringe enables physicians to perform PRP and SVF procedures to treat various patient concerns.
Arthrex Personalized Cell Therapy is a PRP procedure (PRP = platelet rich plasma) which harnesses the body’s own healing and regeneration processes. PRP’s medicinal effect originates from a multitude of growth factors and signaling molecules found in platelets and blood plasma.
The innovative PRP system from Arthrex allows simple preparation of clinically evaluated and proven PRP without having to compromise on safety and quality.
- Two-in-one – Unique double syringe system for the preparation of autologous conditioned plasma
- Time-saving – ACP preparation can be performed within minutes
- Closed system – Enables use in a clinic or under sterile conditions in an OR
- Safe and easy – The double syringe design allows for easy, convenient and safe handling of ACP
Platelet rich plasma has been clinically validated and established as a treatment concept in a wide variety of medical disciplines for a long time.
PRP particularly appeals to patients looking for a natural treatment result without the use of foreign substances such as botulinum toxin or hyaluronic acid. PRP injections are met with a high degree of patient satisfaction and, thanks to the closed Arthrex ACP double syringe, which in the case of PRP does not encounter a separation gel or anticoagulants, are also a well-tolerated procedure.
In addition to aesthetic medicine, dermatology, and plastic surgery, PRP has also been used in orthopedics and sports medicine for many years, primarily to treat muscle and tendon injuries, but also in the treatment of arthritis.
Since the procedure was approved for professional athletes by the World Anti-Doping Agency (WADA) in 2011, it has also been successfully employed by many team physicians, including those of renowned soccer and basketball teams, to get players back in the game more quickly after injuries.
PRP has also been successfully used for several years now in the field of wound healing, especially in cases of wounds requiring complex treatment such as diabetic foot ulcers. The local administration of concentrated, autologous growth factors speeds up the wound healing process. Numerous studies have shown that, compared with conventional treatment, PRP improves wound healing and reduces the development of infections.
Arthrex ACA SVF
The ACA (autologous conditioned adipose tissue) technique offers an easy and fast solution for harvesting and processing adipose tissue to generate ACA SVF.
The SVF is isolated by mechanical dissociation of the adipocytes whereby the regenerative cells within the SVF can be collected as a pellet. SVF comprises some endothelial cells, smooth muscle cells, erythrocytes, leukocytes, adipocytes and the extracellular matrix which can act as a temporary scaffold that also contains matrix remodeling enzymes.
Major Effects of SVF
- Reduction of local inflammation
- Prevention of tissue fibrosis
- Supports angiogenesis and tissue remodeling